Topical sulindac therapy in diabetic senile cataracts : cataract IV

Sulindac, a non-steroidal anti-inflammatory drug has been found to be a potent inhibitor of enzyme aldose reductase. We used sulindac topically in diabetic senile cataract patients to note if it effects the progression of cataracts. More of sulindac treated eyes maintained initial vision and fewer e...

Full description

Bibliographic Details
Main Authors: Sharma Y, Vajpayee R, Bhatnagar R, Mohan Madan, Azad R, Kumar Mukesh, Nath Ram
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 1989-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=Sharma
_version_ 1819107180546097152
author Sharma Y
Vajpayee R
Bhatnagar R
Mohan Madan
Azad R
Kumar Mukesh
Nath Ram
author_facet Sharma Y
Vajpayee R
Bhatnagar R
Mohan Madan
Azad R
Kumar Mukesh
Nath Ram
author_sort Sharma Y
collection DOAJ
description Sulindac, a non-steroidal anti-inflammatory drug has been found to be a potent inhibitor of enzyme aldose reductase. We used sulindac topically in diabetic senile cataract patients to note if it effects the progression of cataracts. More of sulindac treated eyes maintained initial vision and fewer eyes had visual loss of up to two lines or more as compared to control eyes. The extent and density of different opacities showed less progression in sulindac treated eyes but it was not statistically significant except that the ophthalmoscopically observed density of opacity showed statistically very significant lesser mean increase in sulindac treated eyes. We suggest that sulindac is a potential drug which should be further evaluated in large double blind photodocumented studies in diabetic senile cataracts.
first_indexed 2024-12-22T02:49:56Z
format Article
id doaj.art-8b3449e038724e549df5b82004cda612
institution Directory Open Access Journal
issn 0301-4738
language English
last_indexed 2024-12-22T02:49:56Z
publishDate 1989-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-8b3449e038724e549df5b82004cda6122022-12-21T18:41:24ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381989-01-01373127133Topical sulindac therapy in diabetic senile cataracts : cataract IVSharma YVajpayee RBhatnagar RMohan MadanAzad RKumar MukeshNath RamSulindac, a non-steroidal anti-inflammatory drug has been found to be a potent inhibitor of enzyme aldose reductase. We used sulindac topically in diabetic senile cataract patients to note if it effects the progression of cataracts. More of sulindac treated eyes maintained initial vision and fewer eyes had visual loss of up to two lines or more as compared to control eyes. The extent and density of different opacities showed less progression in sulindac treated eyes but it was not statistically significant except that the ophthalmoscopically observed density of opacity showed statistically very significant lesser mean increase in sulindac treated eyes. We suggest that sulindac is a potential drug which should be further evaluated in large double blind photodocumented studies in diabetic senile cataracts.http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=SharmaSulindacaldose reductasedia-betic senile cataractsprostaglandin pathways
spellingShingle Sharma Y
Vajpayee R
Bhatnagar R
Mohan Madan
Azad R
Kumar Mukesh
Nath Ram
Topical sulindac therapy in diabetic senile cataracts : cataract IV
Indian Journal of Ophthalmology
Sulindac
aldose reductase
dia-betic senile cataracts
prostaglandin pathways
title Topical sulindac therapy in diabetic senile cataracts : cataract IV
title_full Topical sulindac therapy in diabetic senile cataracts : cataract IV
title_fullStr Topical sulindac therapy in diabetic senile cataracts : cataract IV
title_full_unstemmed Topical sulindac therapy in diabetic senile cataracts : cataract IV
title_short Topical sulindac therapy in diabetic senile cataracts : cataract IV
title_sort topical sulindac therapy in diabetic senile cataracts cataract iv
topic Sulindac
aldose reductase
dia-betic senile cataracts
prostaglandin pathways
url http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=Sharma
work_keys_str_mv AT sharmay topicalsulindactherapyindiabeticsenilecataractscataractiv
AT vajpayeer topicalsulindactherapyindiabeticsenilecataractscataractiv
AT bhatnagarr topicalsulindactherapyindiabeticsenilecataractscataractiv
AT mohanmadan topicalsulindactherapyindiabeticsenilecataractscataractiv
AT azadr topicalsulindactherapyindiabeticsenilecataractscataractiv
AT kumarmukesh topicalsulindactherapyindiabeticsenilecataractscataractiv
AT nathram topicalsulindactherapyindiabeticsenilecataractscataractiv